loadpatents
Patent applications and USPTO patent grants for Queva; Christophe.The latest application filed is for "encapsulated rna polynucleotides and methods of use".
Patent | Date |
---|---|
Anti-TIGIT antibodies Grant 11,439,705 - Cooper , et al. September 13, 2 | 2022-09-13 |
Encapsulated Rna Polynucleotides And Methods Of Use App 20220117902 - LERNER; Lorena ;   et al. | 2022-04-21 |
Targeted Binding Agents Against B7-h1 App 20210017282 - QUEVA; CHRISTOPHE ;   et al. | 2021-01-21 |
Anti-tigit Antibodies App 20200407445 - Cooper; Anthony ;   et al. | 2020-12-31 |
Oncolytic Viral Vectors And Uses Thereof App 20200206285 - FINER; Mitchell H. ;   et al. | 2020-07-02 |
Anti-tigit Antibodies App 20190315867 - Cooper; Anthony ;   et al. | 2019-10-17 |
Targeted binding agents against B7-H1 Grant 10,400,039 - Queva , et al. Sep | 2019-09-03 |
Anti-TIGIT antibodies Grant 10,329,349 - Cooper , et al. | 2019-06-25 |
Anti-tigit Antibodies App 20190100591 - Cooper; Anthony ;   et al. | 2019-04-04 |
Combination Therapies For Treating B-cell Malignancies App 20180353512 - Collins; Helen ;   et al. | 2018-12-13 |
Combination Therapies For Treating Cancers App 20180207164 - Abella; Esteban M. ;   et al. | 2018-07-26 |
Targeted Binding Agents Against B7-h1 App 20170137522 - QUEVA; CHRISTOPHE ;   et al. | 2017-05-18 |
Therapies For Treating Cancers App 20160331754 - Dansey; Roger ;   et al. | 2016-11-17 |
Targeted binding agents against B7-H1 Grant 9,493,565 - Queva , et al. November 15, 2 | 2016-11-15 |
Therapies For Treating Myeloproliferative Disorders App 20160279135 - Lannutti; Brian ;   et al. | 2016-09-29 |
Therapies For Treating Myeloproliferative Disorders App 20150148345 - Lannutti; Brian ;   et al. | 2015-05-28 |
Targeted Binding Agents Against B7-h1 App 20140356353 - QUEVA; CHRISTOPHE ;   et al. | 2014-12-04 |
Targeted binding agents against B7-H1 Grant 8,779,108 - Queva , et al. July 15, 2 | 2014-07-15 |
Targeted Binding Agents Against B7-H1 App 20130034559 - Queva; Christophe ;   et al. | 2013-02-07 |
Antibodies Directed to CD20 and Uses Thereof App 20110129412 - Gazit-Bornstein; Gadi ;   et al. | 2011-06-02 |
Antibodies directed to CD20 and uses thereof App 20070014720 - Gazit-Bornstein; Gadi ;   et al. | 2007-01-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.